Physician profile
Peter Morcos
NPI 1922207430
$2,909.75
in general payments reported to CMS, 2019-2025
30 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,514 · 2020: $299 · 2021: $58.31 · 2022: $160 · 2023: $347 · 2024: $285 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $489.61 | 2019-2025 | |
| Pfizer INC. | $397.43 | 2019-2022 | |
| Amgen INC. | $357.45 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $140.84 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.62 | 2019-2021 | |
| Glaxosmithkline, LLC. | $131.14 | 2019 | |
| Abbott Laboratories | $128.70 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Boston Scientific Corporation | $126.59 | 2020-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.15 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $101.90 | 2019-2024 | Camzyos |
| Philips North America LLC | $87.33 | 2023 | |
| Irhythm Technologies, INC. | $80.59 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $75.51 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $58.21 | 2019 | |
| Alnylam Pharmaceuticals INC. | $50.39 | 2024 | Amvuttra |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $49.30 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $49.11 | 2019-2020 | |
| Biotronik INC. | $47.61 | 2019 | |
| Esperion Therapeutics, INC. | $34.36 | 2023-2024 | Nexletol |
| Baxter Healthcare | $32.95 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $30.86 | 2019 | |
| Kestra Medical Technology Services, INC. | $24.92 | 2024 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $23.45 | 2019 | |
| Amarin Pharma, INC. | $21.45 | 2019 | |
| Antares Pharma, INC. | $20.76 | 2019 | |
| W. L. Gore & Associates, INC. | $18.89 | 2020 | |
| Medtronic Vascular, INC. | $18.57 | 2019 | |
| Novo Nordisk INC | $16.11 | 2023 | Rybelsus, Ozempic |
| Cvrx, INC. | $15.25 | 2024 | Barostim Neo System |
| Sanofi Pasteur INC. | $14.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Morcos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.